Back
Xtacy Therapeutics Vs. Quinsam Capital Industry Stock Comparison
Sell
32
XTCY.CX
Xtacy Therapeutics
Last Price:
0.03
Seasonality Move:
-22.76%
Sell
40
QCA.CX
Quinsam Capital
Last Price:
0.05
Seasonality Move:
8.91%
Sell
32
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Quinsam Capital (QCA.CX)
is a Sell
Is Quinsam Capital a Buy, Sell or Hold?
- The current Quinsam Capital [QCA.CX] share price is $0.05. The Score for QCA.CX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- QCA.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.03
The current trend is relatively stagnant and XTCY.CX is experiencing slight buying pressure.
QCA.CX Stock Price Chart
What is Quinsam Capital's stock price today?
-
The Quinsam Capital share price today is $0.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QCA.CX is experiencing slight buying pressure.
XTCY.CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 44.83 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.02 - 0.04) | Sell |
Bollinger Bands (100): | (0.03 - 0.05) | Sell |
QCA.CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 45.7 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.05 - 0.05) | Sell |
Bollinger Bands (100): | (0.05 - 0.05) | Sell |
XTCY.CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.02 | Buy |
20-day SMA: | 0.03 | Sell |
50-day SMA: | 0.03 | Sell |
200-day SMA: | 0.04 | Sell |
8-day EMA: | 0.02 | Buy |
20-day EMA: | 0.03 | Sell |
50-day EMA: | 0.03 | Sell |
200-day EMA: | 0.04 | Sell |
QCA.CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.05 | Sell |
20-day SMA: | 0.05 | Sell |
50-day SMA: | 0.05 | Sell |
200-day SMA: | 0.05 | Sell |
8-day EMA: | 0.05 | Sell |
20-day EMA: | 0.05 | Sell |
50-day EMA: | 0.05 | Sell |
200-day EMA: | 0.05 | Sell |
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Quinsam Capital Earnings Growth & QCA.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Xtacy Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Quinsam Capital Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |